RxDoctor Payments Data

Cynthia Harper, NP

Family · Lake Havasu City, AZNPI 1598426330

Payments from drug & device makers

$683in general payments, 2019–2025

Across 12 payments — averaging $56.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$302
  • Sanofi-aventis U.S. LLC$143
  • Regeneron Healthcare Solutions, Inc.$118
  • Novartis$26
  • Viatris Specialty LLC$23
  • Lilly USA, LLC$19
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$54079%
  • Education$14321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$683 in reported general payments places this provider in the 60th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$57,386
Medicare patients
247
Services billed
661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter243$219,466
Breztri AerosphereBudesonide/Glycopyr/Formoterol211$165,914
Spiriva RespimatTiotropium Bromide126$94,712
Tadalafil22$41,807
Stiolto RespimatTiotropium Br/Olodaterol Hcl46$35,594
Spiriva HandihalerTiotropium Bromide31$27,964
SymbicortBudesonide/Formoterol Fumarate73$27,085
Incruse ElliptaUmeclidinium Bromide60$26,110
Breo ElliptaFluticasone/Vilanterol51$25,929
Combivent RespimatIpratropium/Albuterol Sulfate41$23,748
Albuterol Sulfate HfaAlbuterol Sulfate820$23,472
DuleraMometasone/Formoterol53$18,835
BreynaBudesonide/Formoterol Fumarate90$16,690
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$15,979
Fluticasone-SalmeterolFluticasone Propion/Salmeterol103$14,520

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$302$202,833302 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,119 family providers in Arizona.

Other family in Lake Havasu City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →